RE:Looking forward to 2023
I won't be entirely suprised if we get a massive share price increase because the current grift can't last.
I mean look at the attitude here compared to before the aducanumab fiasco https://endpts.com/icer-on-alzheimers-lecanemab-should-be-priced-lower-than-aduhelm/
Everyone knows it's now time to clear an obsolte inventory of brain bleeding drugs that were never going to significantly mitigate the demographic dementia crisis, but as long as big pharma controlled essentially all western research funding there was going to be time to run a military grade grift with the possible bonuse of destroying Medicare.
So what happens if some small cap produces a drug which actually threatens to work? Aducanumab may have changed the landscape alright, just not the way Gene and Elliot expected.